PORT ST LUCIE, Fla., May 10, 2013 /PRNewswire/ -- CleanPath Resources Corp (OTC Pink: CLNP) (www.re-load.biz) CleanPath Resources' newest research and development partner, BioSwan, Inc., just announced new research initiatives for its stem cell enhancement product NutraLoad™. The next phase of research will take place in Europe and Asia and will be focused on NutraLoad™'s efficacy on targeted health issues.
For the past 24 months BioSwan™ has been evaluating and validating the ability of NutraLoad™ to increase the level of stem cells in the circulatory system. These evaluations have been very promising and they have taken place with test patients in a medical facility located in Henderson, Nevada . The response to the product has been very positive creating a great deal of excitement for the official release of NutraLoad™. BioSwan™ will release the results of its Nevada research to CLNP very soon.
CleanPath's CEO Ken Lewis stated, "The positive results from the first round of testing have justified more in depth studies and has shown NutraLoad™ to be an excellent product well worth the wait."
SOURCE CleanPath Resources Corp